Navigation Links
Cepheid Reports Second Quarter Revenue of $42.1 Million
Date:7/24/2008

65 Percent Increase in Product Sales Driven by Robust MRSA Growth

SUNNYVALE, Calif., July 24 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the second quarter of 2008 of $42.1 million, an increase of 55% over the second quarter of fiscal 2007. Net loss was $7.5 million, or $(0.13) per share, which compares to revenue of $27.2 million and a net loss of $5.2 million, or $(0.10) per share, in the second quarter of fiscal 2007.

Excluding amortization of purchased intangible assets and stock compensation expenses, non-GAAP net loss for the second quarter was $3.5 million, or $(0.06) per share. This compares to a non-GAAP net loss of $2.7 million, or $(0.05) per share, in the second quarter of fiscal 2007.

"We are continuing to see rapid development of the Healthcare Associated Infection (HAI) market as sales for our Xpert(TM) MRSA test increased by 35% from the first quarter reaching approximately $11 million," said John Bishop, Cepheid's Chief Executive Officer. "Providing the fastest time-to-result in the industry, our GeneXpert(R) System continues to be the HAI molecular platform of choice, resulting in year-over-year growth in our clinical business of 186% for the first half of 2008."

"While our core clinical product laboratory sales grew to record levels in the second quarter, non-core clinical sales of products to other companies were below our expectations and we expect non-core clinical sales of products to other companies to continue to be below our expectations for the remainder of 2008," continued Bishop. "Our gross margin on product sales was also below our expectations as a result of a problem in the production of a cartridge part. Given that this was occurring with high volume production at an incidence rate of less than 1%, this could have taken an extended period to find and resolve. However, our operations team did an outstanding job in quickly finding the cause and correcting the problem w
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Global ... in-depth study on the current state of the Trifluoroacetic ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/27/2014)... 27, 2014  A novel biomarker for rheumatoid ... better identify early-stage disease, when treatment can often ... a new study in The Journal of Rheumatology. ... DGX ) and other institutions found that ... conventional antibody-serum testing, including rheumatoid factor (RF) and ...
(Date:8/27/2014)... Westminster, CO (PRWEB) August 27, 2014 ... image analysis services to the pharmaceutical and medical ... and expansion. The fast growing company has consolidated ... in Aurora and Boulder to Westminster, CO, just north ... and Histology Lab, 7575 W. 103rd Ave., Suite 100, ...
(Date:8/27/2014)... 2014 Tris Pharma, a specialty pharmaceutical company ... that it has been selected as an award winner ... 2014 Awards for Excellence competition in the Business ... of judges from SCORE (Counselors to America,s Small Business) ... honored at a gala event to be held on ...
Breaking Biology Technology:Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Flagship Biosciences Announces Relocation and Expansion 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2
... Pa., Aug. 24 MEDRAD, Inc. has signed a ... to study the impact of automated Fluoro-deoxy-glucose (FDG) administration ... procedures. Clinicians at Moffitt Cancer Center in Tampa, ... measure and infuse patient-specific FDG doses while industrial engineers ...
... , , SAN DIEGO, Aug. ... today announced that Mark Booth has joined the Company as ... of commercial and business development experience to Orexigen. Most ... (TPNA) where he presided over the commercial, medical and scientific ...
... , KVISTGAARD, Denmark, August ... that the US authorities have initiated,negotiations for a ... the,IMVAMUNE(R) smallpox vaccine. This potential new project will ... Advanced Research and,Development Authority) contract for the procurement ...
Cached Biology Technology:MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 4Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE(R) 2
(Date:8/27/2014)... getting effective doses of the HIV drug maraviroc, a ... studies, completed before the drug was licensed in 2007, ... is key to removing maraviroc from the body. The ... the protein including nearly half of African-Americans ... to those who lack the protein even when given ...
(Date:8/27/2014)... grass species frequently found in forests has created a ... American toads, a new University of Georgia study has ... the U.S. in the early 1900s, is one of ... more than a dozen states in the past century, ... in forests, it can survive in widely diverse ecosystems ...
(Date:8/27/2014)... what is described by the Volunteer Wildfire Services of ... Cape provincial government warned residents in certain parts of ... veld fires. A high veld fire danger rating ... coast in the Great Kei and Mnquma area. ... thunderstorms. The thunderstorms bring lightning strikes and subsequent ...
Breaking Biology News(10 mins):Dosage of HIV drug may be ineffective for half of African-Americans 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3
... great mysteries of life is how it began. What physical process ... a living cell? For more than a century, scientists have ... life. Until recently, their focus has been trained on how the ... early Earth, or perhaps in space. But because it happened so ...
... firing in a brain reward circuit instantly rendered mice ... a study supported by the National Institutes of Health ... mimic the pattern, previously resilient mice instantly succumbed to ... they avoided other animals and lost their sweet ...
... of Notre Dame biochemist Anthony S. Serianni is providing ... and treating diabetes. Serianni points out that biological ... human body from the natural breakdown of the simple ... in diabetic patients because glucose concentrations in the blood ...
Cached Biology News:ASU researchers propose new way to look at the dawn of life 2ASU researchers propose new way to look at the dawn of life 3Stress-resilience/susceptibility traced to neurons in reward circuit 2Stress-resilience/susceptibility traced to neurons in reward circuit 3Stress-resilience/susceptibility traced to neurons in reward circuit 4Notre Dame research may have important implications for combating diabetes 2
... centrifugal filters are disposable microfiltration devices for the ... the range 100 l to 500 l. They ... 2.2 ml centrifuge tubes. Product Features: ... Low hold up volume ( Fast ...
... The ClearSpin Filter is a novel disposable ... the clarification of bacterial lysates in plasmid ... is a novel, disposable spin filtration device ... bacterial lysates in plasmid purification procedures. The ...
... fixed-angle microcentrifuge rotor at RCF up ... filters consist of a membrane-containing filter ... filter by centrifugation for bacteria removal, ... of cells from media and DNA ...
... C, 0.7 mm depth • Reusable, press-to-seal ... be quickly assembled and disassembled for hybridizing ... of any thickness with up to a ... chambers per slide. Minimize specimen handling, eliminate ...
Biology Products: